Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab.
Ho TC, Maamari RN, Kossler AL, Sears CM, Freitag SK, Reshef ER, Shinder R, Rootman DB, Diniz SB, Kahana A, Schlachter D, Do TH, Kally P, Turner S, Mokhtarzadeh A, Harrison AR, Hwang CJ, Kim HJ, Avila SA, Thomas DA, Magazin M, Wester ST, Lee WW, Clauss KD, Holds JB, Sniegowski M, Compton CJ, Briggs C, Malik AI, Lucarelli MJ, Burkat CN, Patel LG, Couch SM. Ho TC, et al. Among authors: sears cm. Ophthalmic Plast Reconstr Surg. 2023 Mar-Apr 01;39(2):150-155. doi: 10.1097/IOP.0000000000002267. Epub 2022 Sep 9. Ophthalmic Plast Reconstr Surg. 2023. PMID: 36095848 Free PMC article.
Microphthalmia and orbital cysts in DiGeorge syndrome.
Chandramohan A, Sears CM, Huang LC, Beres S, Fredrick D, Kossler AL. Chandramohan A, et al. Among authors: sears cm. J AAPOS. 2021 Dec;25(6):358-360. doi: 10.1016/j.jaapos.2021.06.001. Epub 2021 Sep 29. J AAPOS. 2021. PMID: 34597781 Free PMC article.
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease.
Sears CM, Azad AD, Amarikwa L, Pham BH, Men CJ, Kaplan DN, Liu J, Hoffman AR, Swanson A, Alyono J, Lee JY, Dosiou C, Kossler AL. Sears CM, et al. Am J Ophthalmol. 2022 Aug;240:1-13. doi: 10.1016/j.ajo.2022.02.015. Epub 2022 Feb 25. Am J Ophthalmol. 2022. PMID: 35227694 Free PMC article.
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Dosiou C, Cockerham KP, Wester ST, Douglas RS, Kossler AL. Shah SA, et al. Among authors: sears cm. Ophthalmology. 2024 Apr;131(4):458-467. doi: 10.1016/j.ophtha.2023.10.018. Epub 2023 Oct 16. Ophthalmology. 2024. PMID: 37852417
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Men CJ, Amarikwa L, Pham B, Sears C, Clauss K, Lee BW, Lee WW, Pasol J, Ugradar S, Shinder R, Cockerham K, Wester S, Douglas R, Kossler AL. Men CJ, et al. Ophthalmic Plast Reconstr Surg. 2023 Nov 16. doi: 10.1097/IOP.0000000000002564. Online ahead of print. Ophthalmic Plast Reconstr Surg. 2023. PMID: 37972960
28 results